Načítá se...
Bioavailability of oxycodone by mouth in coronary artery bypass surgery patients – a randomized trial
OBJECTIVE: Pain after coronary artery by-pass (CAB) surgery is severe. Analgesic administration by mouth is unreliable until after gastrointestinal function has recovered. We evaluated the bioavailability of oxycodone co-administered with naloxone by mouth in patients after CAB surgery using either...
Uloženo v:
| Vydáno v: | J Drug Assess |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Taylor & Francis
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470105/ https://ncbi.nlm.nih.gov/pubmed/32939317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21556660.2020.1797753 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|